445 related articles for article (PubMed ID: 18590693)
1. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.
Dong XC; Copps KD; Guo S; Li Y; Kollipara R; DePinho RA; White MF
Cell Metab; 2008 Jul; 8(1):65-76. PubMed ID: 18590693
[TBL] [Abstract][Full Text] [Related]
2. The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis.
Guo S; Copps KD; Dong X; Park S; Cheng Z; Pocai A; Rossetti L; Sajan M; Farese RV; White MF
Mol Cell Biol; 2009 Sep; 29(18):5070-83. PubMed ID: 19596788
[TBL] [Abstract][Full Text] [Related]
3. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.
Dong X; Park S; Lin X; Copps K; Yi X; White MF
J Clin Invest; 2006 Jan; 116(1):101-14. PubMed ID: 16374520
[TBL] [Abstract][Full Text] [Related]
4. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ
Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295
[TBL] [Abstract][Full Text] [Related]
5. Foxo1 integrates insulin signaling with mitochondrial function in the liver.
Cheng Z; Guo S; Copps K; Dong X; Kollipara R; Rodgers JT; Depinho RA; Puigserver P; White MF
Nat Med; 2009 Nov; 15(11):1307-11. PubMed ID: 19838201
[TBL] [Abstract][Full Text] [Related]
6. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding.
Kubota N; Kubota T; Itoh S; Kumagai H; Kozono H; Takamoto I; Mineyama T; Ogata H; Tokuyama K; Ohsugi M; Sasako T; Moroi M; Sugi K; Kakuta S; Iwakura Y; Noda T; Ohnishi S; Nagai R; Tobe K; Terauchi Y; Ueki K; Kadowaki T
Cell Metab; 2008 Jul; 8(1):49-64. PubMed ID: 18590692
[TBL] [Abstract][Full Text] [Related]
7. FoxO1 links hepatic insulin action to endoplasmic reticulum stress.
Kamagate A; Kim DH; Zhang T; Slusher S; Gramignoli R; Strom SC; Bertera S; Ringquist S; Dong HH
Endocrinology; 2010 Aug; 151(8):3521-35. PubMed ID: 20501674
[TBL] [Abstract][Full Text] [Related]
8. Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice.
Simmgen M; Knauf C; Lopez M; Choudhury AI; Charalambous M; Cantley J; Bedford DC; Claret M; Iglesias MA; Heffron H; Cani PD; Vidal-Puig A; Burcelin R; Withers DJ
Diabetologia; 2006 Mar; 49(3):552-61. PubMed ID: 16404553
[TBL] [Abstract][Full Text] [Related]
9. FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.
Stöhr O; Tao R; Miao J; Copps KD; White MF
Cell Rep; 2021 Mar; 34(12):108893. PubMed ID: 33761350
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice.
González-Rodríguez A; Mas Gutierrez JA; Sanz-González S; Ros M; Burks DJ; Valverde AM
Diabetes; 2010 Mar; 59(3):588-99. PubMed ID: 20028942
[TBL] [Abstract][Full Text] [Related]
11. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
12. IRS2 signaling in LepR-b neurons suppresses FoxO1 to control energy balance independently of leptin action.
Sadagurski M; Leshan RL; Patterson C; Rozzo A; Kuznetsova A; Skorupski J; Jones JC; Depinho RA; Myers MG; White MF
Cell Metab; 2012 May; 15(5):703-12. PubMed ID: 22560222
[TBL] [Abstract][Full Text] [Related]
13. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
14. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
15. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
[TBL] [Abstract][Full Text] [Related]
16. Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.
Zhang K; Li L; Qi Y; Zhu X; Gan B; DePinho RA; Averitt T; Guo S
Endocrinology; 2012 Feb; 153(2):631-46. PubMed ID: 22147007
[TBL] [Abstract][Full Text] [Related]
17. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
18. Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.
Park WH; Pak YK
Exp Mol Med; 2011 Oct; 43(10):571-9. PubMed ID: 21817852
[TBL] [Abstract][Full Text] [Related]
19. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance.
Duan C; Yang H; White MF; Rui L
Mol Cell Biol; 2004 Sep; 24(17):7435-43. PubMed ID: 15314154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
